The first hospital in Peking University is established "

The first hospital in Peking University is established " The blood tumour centre "

It is reported ' Reporter Li Ying) In order to facilitate the vast blood tumour patient, " blood tumour centre " was established a few days ago in the first hospital in Peking University .

The hematology of BJ Univ Hospital is national-level clinical key discipline and national blood systematic disease diagnosis and rescue center, diagnosis and treating the field and is in national leading position in diseases such as leukemia, lymphoma, taking place bone marrow tumour,etc.. From the year 2003 till now, under the circumstances that head of the department Professor Ren HanYun leads, have launched the highly difficult HLA worthy ofing type and does not conform to the person who supports relation of blood reason, there are no person who supports blood relationship and hematopoietic stem cell of umbilicus blood to transplant smoothly, and made great success. Since the hematopoietic stem cell of body transplants and treats a kind of sex change of primary systemic starch, one pair of shares has nothing to do the blood of umbilicus of persons who support is transplanted and treated adult's blood systematic malignant tumour, the hematopoietic stem cell of different gene transplants and treats the hereditary renal gland brain white matter in field of changing the sex etc. and is in the national leading level.

At present, taking taking the post as professor Chinese cloud as head the intersection of blood and internal medicine department transplant as clinical focal point of work with treatment and hematopoietic stem cell, blood of tumour, will treat competence to bring up to the brand-new height wholly. Here, totally the relieving rate exceeds 80% in acute leukemia, acute for a long time the young long-term survival rate of grains of cell leukemia has been up to 95%, survival rate exceed 70% 5 year in lymphoma, among them high to endanger patient, transplant body survival rate is close 80% 5. 7 year high-level to finish all kinds of hematopoietic stem cells' transplanting and exceeding 300, contain all types that the hematopoietic stem cell transplants, entered the Chinese bone marrow storehouse in the first batch in 2004 and transplanted hospital and stem cell and gathered the hospital. Transplant patient's overall survival rate of 5 years above 70%, among them the steady one of disease carries on allosome and transplants the patient's overall survival rate and already exceeds 80%, transplant success rate, reach world and lead level, some the intersection of transplantation and as world and domestic initiation way at home. Among them, since the hematopoietic stem cell of body transplants and treats a kind of sex change of primary systemic starch, pairs of share have nothing to do person who support the intersection of umbilicus and blood transplant, treat adult blood systematic malignant tumour, high to endanger patient person who support lymphocyte infused (DLI) transplant, Leukemia has been infused, shone the lymphocytes of persons who have supported to carry on immunization therapy since hematopoietic stem cell transplants the body, lymphocytic hyperplasia to diagnose with the intersection of cell and the intersection of immunization therapy,etc. and field in, leading levelling at home in early days disease transplant. Blood internal medicine department have internationally advanced instrument and equipment and examine competence, can finish the intersection of blood and the intersection of tumour and the intersection of cell and science of heredity, molecular genetics, remain the intersection of pathological change and the intersection of person who monitor and many kinds of projects.

"The first hospital hematology is units diagnosing blood tumour and multiple molecule first at home too, can amplify dozens of leukemia genes at the same time, improved the diagnosis level of blood tumour greatly, remain leukemia to monitor after transplanting for the hematopoietic stem cell at the same time, the healing solution is offered the effective basis after adjusting and transplanting. " Professor Ren HanYun introduces, basic research and clinic of immunization therapy are applied to the hematology of BJ Univ Hospital in the ascendant, hematology's bright red is flat for professor to carry on the basic research work for many years in this respect, have launched the immune cell treatment that occuring frequently bone marrow tumour, inert lymphoma and EB virus infected, have obtained better curative effect, has promoted the immunization therapy that virus infecting with and blood tumour recured after transplanting too, the research results are in leading competence at home.

It is reported, the establishment of the blood tumour centre is the combinating of clinical and auxiliary department, it combines the technical force of every relevant department of general hospital, has strengthened the technological cooperation among the relevant departments, can improve the diagnosis, treatment and scientific research level of blood tumour constantly, and set up the tumour disease diagnosis of blood, treat the procedure, serve blood tumour patient better in norm, reach the international level of perfect diagnosis, individual and complex treatment. Offer best medical treatment service for capital and even national common people, it is the ultimate goal which this centre establishes.

The first hospital in Peking University is established " The blood tumour centre "